Experiment summary for ENCSR845CFB
doi:10.17989/ENCSR845CFB
Summary
- Status
- released
- Assay
- DNase-seq
- Biosample summary
- Homo sapiens hematopoietic multipotent progenitor cell treated with interleukin-3 for 8 days, kit ligand for 8 days, hydrocortisone succinate for 8 days, erythropoietin for 8 days
- Biosample Type
- in vitro differentiated cells
- Replication type
- isogenic
- Description
- DNase-seq on 25 year old human male hematopoietic multipotent progenitor cell
- Treatments
- interleukin-3 (UniProtKB:P08700) for 8 days, kit ligand (UniProtKB:P21583) for 8 days, hydrocortisone succinate (CHEBI:31677) for 8 days, erythropoietin (CHEBI:81579) for 8 days
- Nucleic acid type
- DNA
Attribution
ENCODE3 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG007010 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- References
- Date submitted
- March 29, 2015
- Date released
- August 31, 2015
- Treatment Time Series
- ENCSR963OVY
- Annotation (gkmsvm-model)
- Tags
- Registry of cCREs
Encyclopedia Integration
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 1 | 1 | Homo sapiens male adult (25 years) hematopoietic multipotent progenitor in vitro differentiated cells treated with interleukin-3 for 8 days, kit ligand for 8 days, hydrocortisone succinate for 8 days, erythropoietin for 8 days | ENCBS169JBH | ENCLB260IQZ |
| 2 | 1 | Homo sapiens male adult (25 years) hematopoietic multipotent progenitor in vitro differentiated cells treated with interleukin-3 for 8 days, kit ligand for 8 days, hydrocortisone succinate for 8 days, erythropoietin for 8 days | ENCBS418LVC | ENCLB658VAX |
| 3 | 1,2 | Homo sapiens male adult (25 years) hematopoietic multipotent progenitor in vitro differentiated cells treated with interleukin-3 for 8 days, kit ligand for 8 days, hydrocortisone succinate for 8 days, erythropoietin for 8 days | ENCBS575XLE | ENCLB806PSJ |